Kush Parmar, Director at Homology Medicines, Inc. (FIXX), sold 1,000,000 shares at $13.06 ($12.3M) on 2020-12-14, disclosed to the SEC on 2020-12-16.
Open-market sale of $12.3M FIXX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.88 | 13,703 | $163K | 1.3% |
| 2 | $11.88 | 13,703 | $163K | 1.3% |
| 3 | $11.88 | 328,862 | $3.9M | 31.9% |
| 4 | $11.88 | 328,862 | $3.9M | 31.9% |
| 5 | $13.06 | 151,138 | $2.0M | 16.1% |
| 6 | $13.06 | 6,297 |
| $82K |
| 0.7% |
| 7 | $13.06 | 6,297 | $82K | 0.7% |
| 8 | $13.06 | 151,138 | $2.0M | 16.1% |
| Total | $12.25 avg | 1,000,000 | $12.3M | 100% |
| Filing → |
| TRDA | SELL | 2025-11-18 | $3.5M | — | Filing → |
| TRDA | SELL | 2025-07-11 | $405K | — | Filing → |
| TRDA | SELL | 2025-07-01 | $1.6M | — | Filing → |